Cargando…
Severe de novo Ulcerative Colitis following Ixekizumab Therapy
Ixekizumab is a selective monoclonal antibody targeting interleukin-17A, approved for the treatment of chronic plaque psoriasis. It has rarely been associated with inflammatory bowel disease (IBD) in randomized trials only. We report a unique case of severe new-onset ulcerative colitis in a young ma...
Autores principales: | Philipose, Jobin, Ahmed, Moiz, Idiculla, Pretty S., Mulrooney, Stephen M., Gumaste, Vivek V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244035/ https://www.ncbi.nlm.nih.gov/pubmed/30483039 http://dx.doi.org/10.1159/000493922 |
Ejemplares similares
-
A Novel Approach to Percutaneous Endoscopic Gastrostomy Tube Replacement: Can You Save the Site?
por: Philipose, Jobin, et al.
Publicado: (2021) -
Pancreatic Pseudoaneurysm from a Gastroduodenal Artery
por: Gurala, Dhineshreddy, et al.
Publicado: (2019) -
Bouveret’s Syndrome
por: Philipose, Jobin, et al.
Publicado: (2019) -
New onset severe ulcerative colitis following Ixekizumab therapy
por: Morosanu, Alina Mihaela, et al.
Publicado: (2022) -
A Case of Acute Esophageal Necrosis from Unruptured Thoracic Aortic Aneurysm
por: Polavarapu, Abhishek, et al.
Publicado: (2020)